Nephrology Newswire (Page 9)

Nephrology Newswire (Page 9)

Comprehensive Real-Time News Feed for Nephrology. (Page 9)

Results 161 - 180 of 5,675 in Nephrology

  1. University of Michigan and AstraZeneca partner to improve treatment for CKD patientsRead the original story w/Photo

    Nov 10, 2017 | Medical News

    Patients with Chronic Kidney Disease may benefit from a new collaboration between the University of Michigan and AstraZeneca who have partnered to develop a new therapeutic strategy for treatment. The partners will jointly conduct chemistry and drug discovery research with the aim of developing candidate drugs.

    Comment?

  2. CareDx's (CDNA) CEO Peter Maag on Q3 2017 Results - Earnings Call TranscriptRead the original story w/Photo

    Nov 9, 2017 | Seeking Alpha

    ... then provide additional financial details on the quarter. We have just come back from the American Society of Nephrology Meeting in New Orleans and it was exciting to see the interest in AlloSure, our new solution for rejection surveillance for ...

    Comment?

  3. 3SBio (SSRX) and Argos Therapeutics (ARGS) Head-To-Head SurveyRead the original story w/Photo

    Nov 9, 2017 | The Breeze

    ... protein-based products and product candidates are designed to address markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO. In addition, it ...

    Comment?

  4. Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in...Read the original story w/Photo

    Nov 9, 2017 | Circulation

    From the Interdisciplinary Stem Cell Institute , Department of Surgery , Katz Family Division of Nephrology and Hypertension , Department of Medicine , and Department of Radiology , University of Miami Miller School of Medicine, FL; The Emmes Corporation, Rockville, MD ; and Longeveron LLC, Miami, FL . To compare the safety and efficacy of 2 doses of allogeneic bone marrow-derived human mesenchymal stem cells identically delivered in patients with ischemic cardiomyopathy.

    Comment?

  5. Cranston woman with end-stage kidney failure now praying for a 'miracle' donorRead the original story w/Photo

    Nov 9, 2017 | Warwickonline.com

    "It is as simple as that. The problem is, I hate, hate, hate to be the one asking for help.

    Comment?

  6. Republic Services opens hauling facility in north TexasRead the original story w/Photo

    Nov 9, 2017 | Construction & Demolition Recycling

    Phoenix-based Republic Services has unveiled what it describes as its newest and most advanced hauling facility, which is expected to serve customers throughout north Texas for generations. The new 25,000-square-foot-facility located in Lewisville, Texas, features contemporary and collaborative workspace for employees, various employee amenities and modern infrastructure to support hauling and maintenance operations, the company says.

    Comment?

  7. Milwaukee ordinance calls for deconstructionRead the original story w/Photo

    Nov 9, 2017 | Construction & Demolition Recycling

    An approved ordinance in Milwaukee is designed to keep construction and demolition debris out of landfills while still promoting new infrastructure, a report by On Milwaukee says . One to four-family homes built before 1930 that are slated for demolition must be deconstructed rather than torn down.

    Comment?

  8. New treatment approach for autoimmune disorderRead the original story w/Photo

    Nov 3, 2017 | PhysOrg Weblog

    ... blood vessel repair, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). Inhibiting ... (HealthDay) -- A genome-wide association study of antineutrophil cytoplasmic antibody (ANCA)-associated ...

    Comment?

  9. Research reveals presence of potential autoantigen in patients with aggressive kidney diseaseRead the original story w/Photo

    Nov 2, 2017 | Medical News

    ... up the kidney. The findings, which appear in two different studies in the Journ al of the American Society of Nephrology (JASN), suggest that the identified protein may be a potential diagnostic and therapeutic target for FGN. FGN is an aggressive ...

    Comment?

  10. Akari Therapeutics PLC (AKTX) and Its Competitors Critical ContrastRead the original story w/Photo

    Nov 2, 2017 | IntersportsWire

    ... clinical trial of Coversin. It focuses on rare and orphan diseases, including disease states spanning hematology, nephrology, transplantation, neurology and ophthalmology. Receive News & Ratings for Akari Therapeutics PLC Daily - Enter your email ...

    Comment?

  11. Raymond M. Hakim, M.D., Ph.D., FASN, Presented with the Albert Nelson ...Read the original story w/Photo

    Nov 2, 2017 | 24-7 Press Release

    Raymond M. Hakim, M.D., Ph.D., FASN is currently Professor of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Dr. Raymond M. Hakim with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Hakim celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field.

    Comment?

  12. Oral presentation showed impact of ferric citrate on a phosphate-regulating hormone, FGF23Read the original story

    Nov 2, 2017 | PressReleasePoint

    Keryx Biopharmaceuticals, Inc. , a company focused on bringing innovative medicines to people with kidney disease, today announced two presentations of data on AuryxiaA at the 2017 American Society of Nephrology Annual Meeting being held October 31 - November 5, 2017 in New Orleans. The presentations are based on post-hoc analysis of the Phase 3 study of ferric citrate in adults with iron deficiency anemia and non-dialysis dependent chronic kidney disease .

    Comment?

  13. Computer Program Helps Doctors Detect Acute Kidney Injury Earlier to Save LivesRead the original story

    Nov 2, 2017 | PressReleasePoint

    PITTSBURGH, Nov. 2, 2017 - Embedding a decision support tool in the hospital electronic health record increases detection of acute kidney injury, reducing its severity and improving survival, according to new research from the University of Pittsburgh and UPMC. The results, published today in the Journal of the American Society of Nephrology, address one of the most costly and deadly conditions affecting hospitalized patients, providing evidence that computers analyzing changes in renal function can alert doctors of acute kidney injury before the condition is obvious clinically.

    Comment?

  14. Computers can alert doctors of acute kidney injury earlier to help save livesRead the original story w/Photo

    Nov 2, 2017 | Medical News

    Embedding a decision support tool in the hospital electronic health record increases detection of acute kidney injury, reducing its severity and improving survival, according to new research from the University of Pittsburgh and UPMC. The results, published today in the Journal of the American Society of Nephrology , address one of the most costly and deadly conditions affecting hospitalized patients, providing evidence that computers analyzing changes in renal function can alert doctors of acute kidney injury before the condition is obvious clinically.

    Comment?

  15. Keryx Biopharmaceuticals Announces Presentation of Post-Hoc Data From ...Read the original story w/Photo

    Nov 2, 2017 | GlobeNewswire

    Keryx Biopharmaceuticals Announces Presentation of Post-Hoc Data From Phase 3 Study of AuryxiaA in Adults With Iron Deficiency Anemia and Non-dialysis Dependent Chronic Kidney Disease Poster presentation showed effect of ferric citrate when dosed to increase hemoglobin on serum phosphorus in people with normal baseline phosphorus levels NEW ORLEANS, Nov. 02, 2017 -- Keryx Biopharmaceuticals, Inc. , a company focused on bringing innovative medicines to people with kidney disease, today announced two presentations of data on AuryxiaA at the 2017 American Society of Nephrology Annual Meeting being held October 31 - November 5, 2017 in New Orleans.

    Comment?

  16. Health Canada Approves Otsuka and Lundbeck's Abilify Maintena...Read the original story

    Nov 2, 2017 | Customer Interaction Solutions

    ... of life and health of patients through its commitments to neuroscience, cardiovascular health, oncology and nephrology. OCPI was established in 2010, with headquarters in Saint-Laurent, Quebec. OCPI is part of Otsuka Pharmaceutical Co., Ltd., a ...

    Comment?

  17. View Press ReleaseRead the original story w/Photo

    Nov 2, 2017 | Business Wire

    ... of life and health of patients through its commitments to neuroscience, cardiovascular health, oncology and nephrology. OCPI was established in 2010, with headquarters in Saint-Laurent, Quebec. OCPI is part of Otsuka Pharmaceutical Co., Ltd., a ...

    Comment?

  18. Researchers Identify Potential Autoantigen in Aggressive Form of Kidney DiseaseRead the original story w/Photo

    Nov 2, 2017 | Newswise

    ... up the kidney. The findings, which appear in two different studies in the Journ al of the American Society of Nephrology (JASN), suggest that the identified protein may be a potential diagnostic and therapeutic target for FGN. FGN is an aggressive ...

    Comment?

  19. Doctor to conduct skin cancer seminarRead the original story w/Photo

    Jan 30, 2017 | Ogdensburg Courier-Observer/Journal

    Skin cancer is the most common form of cancer, according to the American Cancer Society. Massena Memorial Hospital's Ear-Nose-Throat physician and St. Lawrence County's only Facial Plastic Surgeon Dr. Henri Gaboriau, FACS is presenting a free community seminar entitled “Skin Cancer – Signs, Symptoms and Treatments” at 6 p.m. on Nov. 9, in the hospital's board room to help educate the public on the signs, symptoms and treatment for skin cancer.

    Comment?

  20. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story w/Photo

    Nov 2, 2017 | Business Wire

    Highlights Net revenues increased 1% to $122.... )--On November 1, 2017, Nautic Partners, LLC announced it created Healthy Eyes Advantage in partnership with ... )--OSI Systems, Inc. today announced that its Security division received a multi-year service contract valued at app... Baxter Supports 27 Abstract Presentations at ASN Kidney Week to Advance Scientific Exchange Focused on New Standards of Renal Care )--Baxter International Inc. , a global innovator in renal care, today announced the presentation of 27 abstracts at the American Association of Nephrology --Click to Tweet this News Flex Pharma, Inc. , a clinical-stage biotechnology company that is developing innovative and proprietary treatments for cramps and sp... )--Praxair, Inc. is offering a limited number of in-kind grants to select North American universities through its surface technologies business.

    Comment?